Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid for Post-operative Atrial Fibrillation
NCT01580683Phase 3Withdrawn
- Sponsor
- Regional Hospital of Scranton
- Start
- Jul 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid in Atrial fibrillation (AFib), sponsored by Regional Hospital of Scranton. Planned start Jul 2012; status: withdrawn.
02
Drugs
ascorbic acid
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01580683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01580683.